Larynx Squamous Cell Carcinoma Clinical Trials

6 clinical trials for Larynx Squamous Cell Carcinoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel — RECRUITING
• A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) — RECRUITING · PHASE2
• Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer — RECRUITING · NA
• First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients — ACTIVE_NOT_RECRUITING · PHASE2
• Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. — TERMINATED · PHASE2
• IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma — COMPLETED · PHASE1

Refine this search